Partner News & Updates
-
Partner News
Acquisition significantly expands Janssen’s eye disease portfolio and strengthens its gene therapy capabilities. Late-stage AMD affects millions of people with no effective treatments currently available .
-
Abfero Targeting Excess Iron to Treat AMD, Other Retinal Diseases
Partner NewsAn intriguing link between excess body iron and retinal degeneration is being explored by Abfero Pharmaceuticals, a young biotech based in Boston and Oxford, UK.
Irure eu commodo proident esse. Mollit reprehenderit consequat consectetur veniam occaecat ad dolore adipisicing anim adipisicing officia est laborum mollit. Sunt ullamco ea qui enim aliquip pariatur. Aliquip duis laborum cillum incididunt Lorem commodo cillum velit dolore. Non nostrud cillum ut. Ipsum eiusmod incididunt esse. Voluptate cupidatat reprehenderit nulla aute dolor mollit et nulla commodo tempor excepteur. Nisi ea magna anim ipsum nostrud velit sit mollit ipsum.
